Last reviewed · How we verify

Fuling Yunhua Granules

Beijing Supreme Life Pharmaceutical Technology Co., Ltd. · Phase 2 active Small molecule

Fuling Yunhua Granules is a Small molecule drug developed by Beijing Supreme Life Pharmaceutical Technology Co., Ltd.. It is currently in Phase 2 development. Also known as: prescription A.

At a glance

Generic nameFuling Yunhua Granules
Also known asprescription A
SponsorBeijing Supreme Life Pharmaceutical Technology Co., Ltd.
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Fuling Yunhua Granules

What is Fuling Yunhua Granules?

Fuling Yunhua Granules is a Small molecule drug developed by Beijing Supreme Life Pharmaceutical Technology Co., Ltd..

Who makes Fuling Yunhua Granules?

Fuling Yunhua Granules is developed by Beijing Supreme Life Pharmaceutical Technology Co., Ltd. (see full Beijing Supreme Life Pharmaceutical Technology Co., Ltd. pipeline at /company/beijing-supreme-life-pharmaceutical-technology-co-ltd).

Is Fuling Yunhua Granules also known as anything else?

Fuling Yunhua Granules is also known as prescription A.

What development phase is Fuling Yunhua Granules in?

Fuling Yunhua Granules is in Phase 2.

Related